Perlstein Research Featured

Posted Aug 9, 2010

A new discovery about selective serotonin reuptake inhibitors (SSRIs) in the laboratory of Lewis-Sigler Fellow Ethan Perlstein, suggests that these drugs, which are used to treat mental health disorders like depression and anxiety, have multiple effects on our cells. In a research report published in the August 2010 issue of Genetics, Perlstein and his researchers used yeast cells to identify secondary drug targets or pathways affected by SSRIs.


Share this


Posted by

Profile of Leonid Kruglyak appears in The Scientist

Posted Aug 1, 2010

Leonid Kruglyak, Lewis-Sigler Institute member and Professor of Ecology and Evolutionary Biology, is the subject of a profile in the current issue of The Scientist. The article describes Kruglyak's research on model organisms, and how he designed experiments to tease apart the intricate interactions underlying complex genetic traits in yeast and worms.


Share this


Posted by

Pages